Point prevalence of psychiatric disorders during the second trimester of pregnancy: A population-based study

Liselott Andersson, Inger Sundström Poromaa, Marie Bixo, +3

American Journal of Obstetrics and Gynecology

Perinatal HealthPopulation-based StudyPsychiatryPsychiatric DisordersMaternal Complication +13

Implications of Antenatal Depression and Anxiety for Obstetric Outcome

Liselott Andersson, Inger Sundström Poromaa, Marianne Wulff, +2

Obstetrics and Gynecology

Depression and anxiety during pregnancy and six months postpartum: a follow‐up study

Liselott Andersson, Inger Sundström Poromaa, Marianne Wulff, +2

Acta Obstetricia Et Gynecologica Scandinavica

Progesterone, 5α-pregnane-3,20-dione and 3α-hydroxy-5α-pregnane-20-one in specific regions of the human female brain in different endocrine states

Marie Bixo, Agneta Andersson, Bengt Winblad, +2

Brain Research

Different Endocrine StatesNeuroanatomyUterine ReceptivitySpecific RegionsNeuroendocrinology +11

Estradiol and testosterone in specific regions of the human female brain in different endocrine states

Marie Bixo, Torbjo ̈rn Ba ̈ckstro ̈m, Bengt Winblad, +1

The Journal of Steroid Biochemistry and Molecular Biology

Endocrine MechanismNeurophysiologyNeuroanatomyDifferent Endocrine StatesSpecific Regions +9

Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial

Tone Shetelig Løvvik, Sven Magnus Carlsen, Øyvind Salvesen, +16

The Lancet Diabetes & Endocrinology

InfertilityReproductive HealthGynecologyMaternal HealthGestational Diabetes +9

Combined oral contraceptive use is associated with both improvement and worsening of mood in the different phases of the treatment cycle—A double-blind, placebo-controlled randomized trial

Cecilia Lundin, Kristina Gemzell‐Danielsson, Marie Bixo, +8

Psychoneuroendocrinology

Treatment Cycle—a Double-blindContraceptionContraceptive UseHormonal ContraceptivePsychiatry +13

Treatment of premenstrual dysphoric disorder with the GABAA receptor modulating steroid antagonist Sepranolone (UC1010)—A randomized controlled trial

Marie Bixo, Karin Ekberg, Inger Sundström Poromaa, +7

Psychoneuroendocrinology

Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone

Lotta Andréen, Inger Sundström Poromaa, Marie Bixo, +3

Psychoneuroendocrinology

Hormonal ContraceptivePsychiatryVaginal ProgesteroneReproductive HealthNegative Mood +12

Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder

Birgitta Segebladh, Anna Borgström, Sigrid Nyberg, +2

American Journal of Obstetrics and Gynecology

InfertilityHormonal ContraceptivePremenstrual Dysphoric DisorderPsychiatryReproductive Health +9